US2039082A - Sealing wounds and method of - Google Patents
Sealing wounds and method of Download PDFInfo
- Publication number
- US2039082A US2039082A US2039082DA US2039082A US 2039082 A US2039082 A US 2039082A US 2039082D A US2039082D A US 2039082DA US 2039082 A US2039082 A US 2039082A
- Authority
- US
- United States
- Prior art keywords
- powder
- screen
- swelling
- particles
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 200000000019 wound Diseases 0.000 title description 44
- 238000007789 sealing Methods 0.000 title description 20
- 239000000843 powder Substances 0.000 description 62
- 230000002522 swelling Effects 0.000 description 34
- 239000002245 particle Substances 0.000 description 28
- 239000000126 substance Substances 0.000 description 28
- 238000010438 heat treatment Methods 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 22
- 241000416162 Astragalus gummifer Species 0.000 description 18
- 229920001615 Tragacanth Polymers 0.000 description 18
- 239000007788 liquid Substances 0.000 description 18
- 229940116362 Tragacanth Drugs 0.000 description 16
- 235000010487 tragacanth Nutrition 0.000 description 16
- 239000000196 tragacanth Substances 0.000 description 16
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 14
- 240000008886 Ceratonia siliqua Species 0.000 description 14
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 14
- 240000005158 Phaseolus vulgaris Species 0.000 description 14
- 229920000591 gum Polymers 0.000 description 14
- 230000000717 retained Effects 0.000 description 14
- 206010018987 Haemorrhage Diseases 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 230000000740 bleeding Effects 0.000 description 10
- 231100000319 bleeding Toxicity 0.000 description 10
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 230000001427 coherent Effects 0.000 description 10
- 210000004369 Blood Anatomy 0.000 description 8
- 206010048629 Wound secretion Diseases 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 230000002439 hemostatic Effects 0.000 description 8
- 229920000742 Cotton Polymers 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000428 dust Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- 239000011630 iodine Substances 0.000 description 6
- 235000015110 jellies Nutrition 0.000 description 6
- 240000001058 Sterculia urens Species 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 230000000249 desinfective Effects 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 230000001954 sterilising Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- KKAJSJJFBSOMGS-UHFFFAOYSA-N Acriflavinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N Chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 229960004926 Chlorobutanol Drugs 0.000 description 2
- 241000934834 Cochlospermum Species 0.000 description 2
- 208000002197 Ehlers-Danlos Syndrome Diseases 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 210000004185 Liver Anatomy 0.000 description 2
- 235000021282 Sterculia Nutrition 0.000 description 2
- 235000015125 Sterculia urens Nutrition 0.000 description 2
- 229940098465 Tincture Drugs 0.000 description 2
- 230000001476 alcoholic Effects 0.000 description 2
- 230000000202 analgesic Effects 0.000 description 2
- 230000002421 anti-septic Effects 0.000 description 2
- 244000052616 bacterial pathogens Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001621 bismuth Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011362 coarse particle Substances 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 108060002971 flz Proteins 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960003172 iodoform Drugs 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000012254 powdered material Substances 0.000 description 2
- 230000001681 protective Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229940059107 sterculia Drugs 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Definitions
- This invention relates to pulverulent prepare-- tions for protecting and sealing wounds, and more particularly for use as a mechanically acting hemastatlc, and relates further to a method of manufacturing each preparations. It is an object of thednyention to provide a preparation which is capable, when brought in contact with the fluid discharge from the wound, to. absorb the same and to form a plaster-like coating which mechanically seals the wound. A further object is to provide a preparation, which through the dormation of a tough elastic skin in the moment of application to bleeding woundsis capable of withstanding the pressure of the blood (within certain limits), so that further hemorrhage is checked. Further objects. of the invention will become apparent in the course of the ensuing description.
- the invention is based upon the discovery that it is necessary, for the purpose of mechanical blood stanching by the formation of a seal, to employ pulverulent swelling substances, such as insoluble kinds of gum exemplified by various varieties of tragacanth, and groundseed kernels oifthe carob bean, having the property, at nor- -mal temperatures up to body-temperature, of
- tragacanth is intended to cover all or the various gums known by that name and including the various species and varieties of Astrcgalus, and the various varieties and specicstoif'Sterculiw and Cochlospermum cossypium.
- Gunt'trom Sterculia is sometimes lifhcwn as Karayct gum, but according to the llritish Pharmaceutical Codex 1923 it is also called Indian tragacanth.
- the pulverulent swelling substances used have the property ot permanently taking up the discharge from the wound, while swelling and forming jellies.
- the swelling velocity of the initial pulverulent substances which in its turn has to do inter alia with their capacity for becoming wetted and secondly the firmness or the gels formed.
- the swelling velocity of powders capable of swelling, and more still the firmness ol' the jelllesformed from these powders on contact with water or aqueous liquids such as blood is dependent to a very considerable extent on t grain size of the powder employed.
- the pulverulent substances used do not contain portions of a grain size exceeding a' certain upper limit.
- the pulverulent substances used if they'are to exhibit the required 5 properties, must be free from particles which are retained by a screen No. 35 (width of opening 0.500 mm). Such powders are still'better suited that in addition are free from particles which are retained by, a screen No. 70 (width of 1 opening 0.210 mm.).
- the starting materials are comminuted, for example in a mill of close set, mortar, or the like, after which at least the coarse'particles, but preferably also the particles of theflneness of dust, are removed.
- the coarse'particles but preferably also the particles of theflneness of dust
- the coarse particles are eliminated;
- the firmness of the gels formed on contact with aqueous liquids may also be considerably increased by subjecting the powder to a heat treatment under such conditions, as regards temperature and duration or the heat actiomthat a noticeable change of the color, generally a change to yellow or brown, takes place.
- This change of the color usually sets in after a period of one hour when heating the powder up to or C., and already after a shorter period when heating to higher temperatures.
- This heat treatment may be effected before dressing the powder to remove the constituents retained by sieve No. 35. But it is also possible to subject the powder already dressed to this heat treatment.
- pulverulent substances according to the present invention when brought in contact in suitable quantities with the liquid discharge, at body-temperature, will swell within a very short time, generallywithin less than fiv seconds, and form an elastic and firm jelly constituting an immediate and firmly adhering protective cover and seal of the wound.
- the swelLng pulverulent substances can be sterilized in a known manner, for example by treatment with antiseptically active substances, preferably with readily evaporating substances of the nature of chloroform, toluol, and the like, or with other known disinfectants such as trypaflavin, bismuth salts, iodoform and the like.
- the heat treatment described above for the purpose of increasing the capacity of the powder of being wetted may be combined in a simple manner with the sterilization, by carefully heating the swelling substances for several hours, for example in a thin layer or with agitation, to a temperature in the neighbourhood of 100 C., whereupon the temperature is increased until the water is practically driven off, which is often the case at 120 C.
- the powder thus treated is now further heated in a closed vessel, for example at temperatures of 120 to C., until the desired capacity of being wetted and the change in color which depend on each other, are attained.
- the powder becomes at the same time sterile.
- inert swelling powders there can also be added to the inert swelling powders substances of specific eificacy, such as styptics, disinfectants, or analgetics, either singly or in combination.
- substances of specific eificacy such as styptics, disinfectants, or analgetics, either singly or in combination.
- the preparations obtained in accordance with the invention can be sold either in the form of a loose powder to be strewn or dusted on to wounds, or can be incorporated in carrier materials such as surgical dressing fabric, cottonwool, lint, paper, plasters, and the like. If a carrier material such as cotton-wool is used the fibrous material is embedded in the gel formed from the powder in contact with the fluid discharge.
- the swelling powders described are capable of absolutely sealing the wounds and at the same time binding the secretion by absorbing it. While swelling, they also permit stanching rapidly and reliably haamorrhages which hitherto have been regarded as incapable of being stanched such as for example hzemorrhages following incisions of the liver.
- a hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a powder of a gum selected from the class consisting of tragacanth and carob bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 35 and are retained by screen No. 200, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
- a hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a powder of a gum selected from the class consisting of tragacanth and carob bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 70 and are retained by screen No. 140, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
- a hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a substantially dehydrated powder of a gum selected from the class consisting of tragacanth and carob bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 70 and are retained by screen No. 140, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
- a hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a substantially dehydrated acsaoee wder oi a seiected from the class consisting of tragacanth and catch bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 35 and are retained by screen No. 200, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
- a process of producing a preparation capable of swelling when in contact with aqueous liquids, for protecting and sealing wounds which consists in comminuting a gum selected from the class consisting oi tragacanth and carob seed kernels to a powder and dressing the said powder to remove "coarse grains.
- a process 01 producing a preparation capable of swelling when in contact with aqueous liquids, for protecting and sealing wounds which consists in comminuting a gum selected from the class consisting of tragacanth and carob bean seed kernels to a powder, dressing the said powder to remove coarse grains and thereafter subjecting the said powder to a heat treatment for such a period and suiificient to substantially dehydrate the same.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Description
till
cot
utentecl Apr. 28; 1936 UNITED STATES accents PREPARATION FOR PROTECTING AND SEALING WOUNDS AND METHOD OF MANUFACTURING THE SAME Karl Jungmann, Aussig-on-the-Elbe, Czechoslovakia No Drawing.
Application December 17, 1934,
Serial No. 757,963. In Germany March 25, 1931 '6 Claims. ((1167-58) This inventionrelates to pulverulent prepare-- tions for protecting and sealing wounds, and more particularly for use as a mechanically acting hemastatlc, and relates further to a method of manufacturing each preparations. It is an object of thednyention to provide a preparation which is capable, when brought in contact with the fluid discharge from the wound, to. absorb the same and to form a plaster-like coating which mechanically seals the wound. A further object is to provide a preparation, which through the dormation of a tough elastic skin in the moment of application to bleeding woundsis capable of withstanding the pressure of the blood (within certain limits), so that further hemorrhage is checked. Further objects. of the invention will become apparent in the course of the ensuing description.
The invention is based upon the discovery that it is necessary, for the purpose of mechanical blood stanching by the formation of a seal, to employ pulverulent swelling substances, such as insoluble kinds of gum exemplified by various varieties of tragacanth, and groundseed kernels oifthe carob bean, having the property, at nor- -mal temperatures up to body-temperature, of
forming immediately, that is to say within'a few,-
generally less than 5. seconds after con-tactiwlth the fluid discharge, coherent andelastlc jellies Whichwill withstandthe pressure of this fluid.
The expression tragacanth is intended to cover all or the various gums known by that name and including the various species and varieties of Astrcgalus, and the various varieties and specicstoif'Sterculiw and Cochlospermum cossypium. Gunt'trom Sterculia is sometimes lifhcwn as Karayct gum, but according to the llritish Pharmaceutical Codex 1923 it is also called Indian tragacanth.
lnsome cases, it is desirable that the pulverulent swelling substances used have the property ot permanently taking up the discharge from the wound, while swelling and forming jellies. For the attainment of this object there are two factors of decisive importance, namely first the swelling velocity of the initial pulverulent substances, which in its turn has to do inter alia with their capacity for becoming wetted and secondly the firmness or the gels formed. I have now found that the swelling velocity of powders capable of swelling, and more still the firmness ol' the jelllesformed from these powders on contact with water or aqueous liquids such as blood, is dependent to a very considerable extent on t grain size of the powder employed. In order to obtain the optimum effect it is necessary that the pulverulent substances used do not contain portions of a grain size exceeding a' certain upper limit. I have found that the pulverulent substances used, if they'are to exhibit the required 5 properties, must be free from particles which are retained by a screen No. 35 (width of opening 0.500 mm). Such powders are still'better suited that in addition are free from particles which are retained by, a screen No. 70 (width of 1 opening 0.210 mm.). I have further found that it is of advantage to use pulverulent substances which are also free from constituents of the fineness of dust, preferably from portions of a grain size to pass through a screen N0. 200 (width oiopening 0.074 mm), and better still from portions of a grain size to pass through a screen No. 140 (width of opening 0.105 mm.).
Any partial fraction lying anywhere between the above given limits may be separated out and used for the purpose in view.
For the purpose of producing powder of this nature, the starting materials are comminuted, for example in a mill of close set, mortar, or the like, after which at least the coarse'particles, but preferably also the particles of theflneness of dust, are removed. For the separating out of the particles to be eliminated there can be employed all the usualmethods, such as screening, wind sifting, and the like. It is simplest to dress the powdered material according to grain sizes, by screening. The coarse particles are eliminated;
by sieving out on a screen No. or any other.
screen between No. 35 and No. 70. Thefinest' particles are then preferably eliminatedbywiev 35 ing out on a screen No..200. It is,however, of advantage, as mentioned above to 'separate out still coarser particles than: those corresponding to screen No. 200. For this purpose for example a screen No. 140 or any screen between Nos. 140 and 200 is taken. The sieve designation here used is that of the U. S. Standard (International Critical Tables of Numerical Data, Physics, Chemistry and Technology, prepared under the auspices of the International Research Council and the National Academy of Sciences by the National Research Council of the U. S. of Am. vol. II, page 329). l
The capacity of the powder-of being wetted and thus its velocity of swelling, and, moreover,
the firmness of the gels formed on contact with aqueous liquids may also be considerably increased by subjecting the powder to a heat treatment under such conditions, as regards temperature and duration or the heat actiomthat a noticeable change of the color, generally a change to yellow or brown, takes place. This change of the color'usually sets in after a period of one hour when heating the powder up to or C., and already after a shorter period when heating to higher temperatures. This heat treatment may be effected before dressing the powder to remove the constituents retained by sieve No. 35. But it is also possible to subject the powder already dressed to this heat treatment.
If pulverulent substances according to the present invention be employed these substances, when brought in contact in suitable quantities with the liquid discharge, at body-temperature, will swell within a very short time, generallywithin less than fiv seconds, and form an elastic and firm jelly constituting an immediate and firmly adhering protective cover and seal of the wound.
The swelLng pulverulent substances can be sterilized in a known manner, for example by treatment with antiseptically active substances, preferably with readily evaporating substances of the nature of chloroform, toluol, and the like, or with other known disinfectants such as trypaflavin, bismuth salts, iodoform and the like.
If the sterilizing is effected by the application of heat, the heat treatment described above for the purpose of increasing the capacity of the powder of being wetted may be combined in a simple manner with the sterilization, by carefully heating the swelling substances for several hours, for example in a thin layer or with agitation, to a temperature in the neighbourhood of 100 C., whereupon the temperature is increased until the water is practically driven off, which is often the case at 120 C. The powder thus treated is now further heated in a closed vessel, for example at temperatures of 120 to C., until the desired capacity of being wetted and the change in color which depend on each other, are attained. The powder becomes at the same time sterile.
There can also be added to the inert swelling powders substances of specific eificacy, such as styptics, disinfectants, or analgetics, either singly or in combination.
The preparations obtained in accordance with the invention can be sold either in the form of a loose powder to be strewn or dusted on to wounds, or can be incorporated in carrier materials such as surgical dressing fabric, cottonwool, lint, paper, plasters, and the like. If a carrier material such as cotton-wool is used the fibrous material is embedded in the gel formed from the powder in contact with the fluid discharge.
In contradistinction to the usual surgical dressing fabrics or the chemical acting agents for treating wounds or blood stanching, which either do not prevent with certainty the penetration of microbes into the wound or hinder the discharge of secretions from the wound, the swelling powders described are capable of absolutely sealing the wounds and at the same time binding the secretion by absorbing it. While swelling, they also permit stanching rapidly and reliably haamorrhages which hitherto have been regarded as incapable of being stanched such as for example hzemorrhages following incisions of the liver.
Examples (1) 1000 grams of ground seeds of the carob bean are first freed from the grained particles which are too coarse, with the aid of screen No. 70, and then from the particles of the fineness of dust by sieving on a screen No. 140. In this latter screen there remain about 550 grams. This sieved fraction is spread out in a thin layer on glass dishes, and heated for 2 hours at about 110? C. in the drying chamber. The product assumes a faintly yellow color in the course of heating. After this drying process the powder is placed in a bottle which is closed with a plug of cotton-wool and heated in the drying chamber for 3 hours at 130 C. The color of the powder will now change to a brownish color and becomes sterile.-
(2) The sieved fraction of 550 grams weight obtained in accordance with Example (1) is uniformly sprinkled with 50 ccs. of a 10% alcoholic solution of trichlore-isobutyl alcohol (chloretone), and the alcohol allowed to evaporate.
(3) The sieved fraction of 550 grams weight obtained in accordance with Example (1) is sprinkled, if desired after heating, with 50 cos. of a 10% solution of iodine in chloroform which is then allowed to evaporate. The disappearance of the chloroform is visible by the iodine changing color from reddish-violet to brown. Tincture of iodine can also be employed, to obtain a strongly antiseptic product.
(4) 1000 grams weight of gum tragacanth are comminuted and heated in the heating chambar for 2 hours to C. The product changes its color after a short time to a faintly yellow color and becomes gradually brownish. The heat treated powder is now sieved on a screen No. 50, and the constituents passing this screen are freed from the dust-like particles by screening on a screen No. 1'70.
' What I claim is:
1. A hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a powder of a gum selected from the class consisting of tragacanth and carob bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 35 and are retained by screen No. 200, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
2. A hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a powder of a gum selected from the class consisting of tragacanth and carob bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 70 and are retained by screen No. 140, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
3. A hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a substantially dehydrated powder of a gum selected from the class consisting of tragacanth and carob bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 70 and are retained by screen No. 140, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
4. A hemostatic preparation capable of swelling when in contact with aqueous liquids for mechanically sealing and protecting bleeding wounds comprising a substantially dehydrated acsaoee wder oi a seiected from the class consisting of tragacanth and catch bean seed kernels, the said powder consisting of particles mainly of such grain sizes as pass through screen No. 35 and are retained by screen No. 200, and forming with the wound secretions a firm coherent coating mass which adheres strongly to the flesh of the wound.
5. A process of producing a preparation capable of swelling when in contact with aqueous liquids, for protecting and sealing wounds which consists in comminuting a gum selected from the class consisting oi tragacanth and carob seed kernels to a powder and dressing the said powder to remove "coarse grains.
6. A process 01 producing a preparation capable of swelling when in contact with aqueous liquids, for protecting and sealing wounds which consists in comminuting a gum selected from the class consisting of tragacanth and carob bean seed kernels to a powder, dressing the said powder to remove coarse grains and thereafter subjecting the said powder to a heat treatment for such a period and suiificient to substantially dehydrate the same.
KARL JUNGMANN.
Publications (1)
Publication Number | Publication Date |
---|---|
US2039082A true US2039082A (en) | 1936-04-28 |
Family
ID=3427839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US2039082D Expired - Lifetime US2039082A (en) | Sealing wounds and method of |
Country Status (1)
Country | Link |
---|---|
US (1) | US2039082A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4225580A (en) * | 1973-01-29 | 1980-09-30 | Pharmacia Aktiebolag | Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method |
US4361552A (en) * | 1980-09-26 | 1982-11-30 | Board Of Regents, The University Of Texas System | Wound dressing |
US4537767A (en) * | 1973-01-29 | 1985-08-27 | Pharmacia Aktiebolag | Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method |
US4538603A (en) * | 1982-04-22 | 1985-09-03 | E. R. Squibb & Sons, Inc. | Dressings, granules, and their use in treating wounds |
US20070086958A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Formation of medically useful gels comprising microporous particles and methods of use |
US20070087061A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components |
-
0
- US US2039082D patent/US2039082A/en not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4225580A (en) * | 1973-01-29 | 1980-09-30 | Pharmacia Aktiebolag | Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method |
US4537767A (en) * | 1973-01-29 | 1985-08-27 | Pharmacia Aktiebolag | Method for cleansing fluid discharging skin surfaces, wounds and mucous membranes and means for carrying out the method |
US4361552A (en) * | 1980-09-26 | 1982-11-30 | Board Of Regents, The University Of Texas System | Wound dressing |
US4538603A (en) * | 1982-04-22 | 1985-09-03 | E. R. Squibb & Sons, Inc. | Dressings, granules, and their use in treating wounds |
US20070086958A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Formation of medically useful gels comprising microporous particles and methods of use |
US20070087061A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2006329661B2 (en) | Hemostatic material | |
US2899362A (en) | Hemostatic sponges and method of | |
EP0025649B1 (en) | Pharmaceutical composition containing sanguinaria and galangal suitable for treatment of periodentitis and tumours | |
DE68918538T2 (en) | Wound filler. | |
AU2006329660B2 (en) | Hemostatic material | |
Draye et al. | In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films | |
US3339546A (en) | Bandage for adhering to moist surfaces | |
JPH06508287A (en) | Adhesive compositions and products | |
JPS6134829B2 (en) | ||
CN105688269B (en) | Modified gelatin hemostatic material and preparation method thereof | |
US2039082A (en) | Sealing wounds and method of | |
JP6716841B2 (en) | Hemostatic material | |
TW201242606A (en) | Hemostatic preparation containing an extract of golden moss | |
DE60020683T2 (en) | HYDROCOLLOID ADHESIVE MASS WITH AN IMPROVED RESISTANCE TO ABSORPTION DEGRADATION CAPACITY AFTER RADIOSTERILIZATION | |
JPS6142531A (en) | Manufacture of microporous powdery polylactide | |
CN113318263A (en) | Antibacterial dressing and preparation method thereof | |
EP3662937A1 (en) | Hemostatic material and wound dressing material containing same | |
RU2006121491A (en) | PROTECTIVE PRODUCT FOR RAS, INCLUDING SUBSTANCE WHICH HINDS THE GROWTH OF BACTERIA IN WOUNDS | |
CH615099A5 (en) | ||
US3842830A (en) | Surgical dressing and method of forming the same | |
CH675833A5 (en) | ||
KR20010109042A (en) | A cataplasma containing an aloe concentrate which shows an anti-inflammatory effect | |
KR101075933B1 (en) | Sponge of manufacturing method for cleansing the skin | |
KR101858835B1 (en) | composition of an aerosol formulation for spray band and method for preparing the same | |
Erza et al. | Antibacterial activity of Allium sativum L. cream formulation against Propionibacterium acnes and Staphylococcus epidermidis |